• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征对急性肺栓塞患者经导管溶栓治疗后平均肺动脉压的影响。

Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.

机构信息

Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, United States of America.

Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, United States of America.

出版信息

Int J Cardiol. 2020 Mar 1;302:138-142. doi: 10.1016/j.ijcard.2019.12.043. Epub 2019 Dec 26.

DOI:10.1016/j.ijcard.2019.12.043
PMID:31948673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7022200/
Abstract

BACKGROUND

Metabolic syndrome (MetS) has been associated with a procoagulant and hypofibrinolytic state. Current data exploring the role of MetS in venous thromboembolism (VTE) are limited. The objective was to measure the prevalence of MetS in patients with acute PE receiving catheter-directed thrombolysis (CDT) and to investigate its effect on mean pulmonary arterial pressure and overall treatment success.

METHODS

We used a 3-year prospective registry of ED patients with acute PE with severity qualifying for activation of a PE response team (PERT). All patients had CDT with catheter-measured mPAP and angiography. The presence or absence of MetS components were extracted from chart review based on the following criteria: 1. body mass index (BMI) >30 kg/m; 2. diagnosed hypertension; 3. diabetes mellitus (including HbA1c >6.5%) and; 4. dyslipidemia (including triglycerides >150 mg/dL or high-density lipoprotein <40 mg/dL).

RESULTS

Of the 134 patients, 85% met the criteria for at least one of four MetS components, with obesity being most common, present in 71%. Results demonstrated a positive concordance between the number of criteria for MetS and MPAP, both pre- and post-fibrinolysis, as pressures tended to increase with each additional MetS criterion. Multivariate regression analysis determined age (-), BMI (+) and hypertension (+) to be significant independent predictor variables for mPAP.

CONCLUSIONS

MetS was common in patients with more severe manifestations of PE and was associated with higher mPAP values both at diagnosis and following treatment with CDT.

摘要

背景

代谢综合征(MetS)与促凝和纤溶活性降低有关。目前探索代谢综合征在接受导管溶栓治疗(CDT)的急性肺栓塞(PE)患者中的作用的数据有限。目的是测量接受 CDT 的急性 PE 患者中代谢综合征的患病率,并探讨其对平均肺动脉压和整体治疗成功率的影响。

方法

我们使用了一项为期 3 年的前瞻性 ED 急性 PE 患者登记研究,其严重程度符合 PE 反应团队(PERT)激活的标准。所有患者均接受 CDT 治疗,并通过导管测量平均肺动脉压和血管造影。根据以下标准从病历回顾中提取代谢综合征成分的存在或缺失:1. 体重指数(BMI)>30kg/m;2. 诊断为高血压;3. 糖尿病(包括 HbA1c>6.5%);4. 血脂异常(包括甘油三酯>150mg/dL 或高密度脂蛋白<40mg/dL)。

结果

在 134 名患者中,85%至少符合四个代谢综合征成分中的一个标准,其中肥胖最常见,占 71%。结果表明,在溶栓前和溶栓后,代谢综合征标准的数量与平均肺动脉压之间存在正相关性,压力随着每增加一个代谢综合征标准而升高。多变量回归分析确定年龄(-)、BMI(+)和高血压(+)是平均肺动脉压的显著独立预测变量。

结论

代谢综合征在表现更严重的 PE 患者中很常见,并且与诊断时和接受 CDT 治疗后的平均肺动脉压值升高有关。

相似文献

1
Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.代谢综合征对急性肺栓塞患者经导管溶栓治疗后平均肺动脉压的影响。
Int J Cardiol. 2020 Mar 1;302:138-142. doi: 10.1016/j.ijcard.2019.12.043. Epub 2019 Dec 26.
2
Metabolic Syndrome Increases Risk of Venous Thromboembolism Recurrence after Acute Pulmonary Embolism.代谢综合征增加急性肺栓塞后静脉血栓栓塞复发风险。
Ann Am Thorac Soc. 2020 Jul;17(7):821-828. doi: 10.1513/AnnalsATS.201907-518OC.
3
Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis.导管定向溶栓治疗大面积和次大面积肺栓塞的安全性:一项多中心注册研究和荟萃分析的结果
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):754-760. doi: 10.1002/ccd.26900. Epub 2017 Feb 1.
4
Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry.肺栓塞对碎裂、栓子切除术和导管溶栓的反应(PERFECT):一项前瞻性多中心注册研究的初步结果
Chest. 2015 Sep;148(3):667-673. doi: 10.1378/chest.15-0119.
5
Catheter-directed aspiration thrombectomy and low-dose thrombolysis for patients with acute unstable pulmonary embolism: Prospective outcomes from a PE registry.急性不稳定型肺栓塞患者的导管定向抽吸血栓切除术和低剂量溶栓治疗:来自肺栓塞登记处的前瞻性结局。
Int J Cardiol. 2019 Jul 15;287:106-110. doi: 10.1016/j.ijcard.2019.02.061. Epub 2019 Feb 28.
6
Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.导管定向溶栓在肺栓塞中的应用以及全身溶栓与导管定向溶栓之间的疗效差异。
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1219-27. doi: 10.1002/ccd.26108. Epub 2015 Aug 26.
7
Comparative Outcomes of Ultrasound-Assisted Thrombolysis and Standard Catheter-Directed Thrombolysis in the Treatment of Acute Pulmonary Embolism.超声辅助溶栓与标准导管定向溶栓治疗急性肺栓塞的比较结果
Vasc Endovascular Surg. 2016 Aug;50(6):405-10. doi: 10.1177/1538574416666228.
8
A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.高、中危肺栓塞导管溶栓治疗结局的荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):530-540. doi: 10.1016/j.jvsv.2018.03.010.
9
Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism.急性大面积肺栓塞患者经皮超声加速溶栓与导管直接溶栓的比较
Vascular. 2009 Nov-Dec;17 Suppl 3:S137-47. doi: 10.2310/6670.2009.00063.
10
Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of acute pulmonary embolism and lower extremity deep venous thrombosis: A novel one-stop endovascular strategy.经皮机械血栓切除术联合导管定向溶栓治疗急性肺栓塞和下肢深静脉血栓形成:一种新型一站式血管内治疗策略。
J Int Med Res. 2018 Feb;46(2):836-851. doi: 10.1177/0300060517729898. Epub 2017 Sep 20.

引用本文的文献

1
Metabolic Syndrome-Related Kidney Injury: A Review and Update.代谢综合征相关肾损伤:综述与更新。
Front Endocrinol (Lausanne). 2022 Jun 23;13:904001. doi: 10.3389/fendo.2022.904001. eCollection 2022.
2
Fibrinolytics for the treatment of pulmonary embolism.纤维蛋白溶解剂治疗肺栓塞。
Transl Res. 2020 Nov;225:82-94. doi: 10.1016/j.trsl.2020.05.003. Epub 2020 May 17.

本文引用的文献

1
Catheter-directed therapy as a treatment for submassive pulmonary embolism: A meta-analysis.导管介入治疗在亚大块肺栓塞治疗中的应用:一项荟萃分析。
Life Sci. 2017 Nov 1;188:17-25. doi: 10.1016/j.lfs.2017.08.031. Epub 2017 Aug 31.
2
Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity.脂肪因子:2型糖尿病和肥胖症血管功能障碍的潜在治疗靶点
J Diabetes Res. 2017;2017:8095926. doi: 10.1155/2017/8095926. Epub 2017 Feb 13.
3
Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.中等风险肺栓塞对纤溶酶原激活剂启动的纤维蛋白溶解存在可变抗性。
PLoS One. 2016 Feb 11;11(2):e0148747. doi: 10.1371/journal.pone.0148747. eCollection 2016.
4
Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases.运动调节衰老和心血管疾病中的氧化应激与炎症。
Oxid Med Cell Longev. 2016;2016:7239639. doi: 10.1155/2016/7239639. Epub 2015 Dec 28.
5
Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.纤维蛋白溶解对急性次大面积肺栓塞后SF-36身体状况总结的影响。
J Thromb Thrombolysis. 2015 Aug;40(2):161-6. doi: 10.1007/s11239-014-1155-5.
6
Adipokines at the crossroad between obesity and cardiovascular disease.肥胖与心血管疾病交叉点上的脂肪因子
Thromb Haemost. 2015 Mar;113(3):553-66. doi: 10.1160/TH14-06-0513. Epub 2014 Oct 23.
7
Metabolic syndrome.代谢综合征
Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. doi: 10.1016/j.ecl.2013.09.009.
8
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.使用 SF-36 和 PEmb-QoL 评估肺栓塞后的生活质量。
Thromb Res. 2013 Nov;132(5):500-5. doi: 10.1016/j.thromres.2013.06.016. Epub 2013 Oct 3.
9
Exercise standards for testing and training: a scientific statement from the American Heart Association.测试与训练的运动标准:美国心脏协会的科学声明。
Circulation. 2013 Aug 20;128(8):873-934. doi: 10.1161/CIR.0b013e31829b5b44. Epub 2013 Jul 22.
10
Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.美国成年人代谢综合征的流行率和趋势,1999-2010 年。
J Am Coll Cardiol. 2013 Aug 20;62(8):697-703. doi: 10.1016/j.jacc.2013.05.064. Epub 2013 Jun 27.